David C. Gillis

434 total citations
23 papers, 333 citations indexed

About

David C. Gillis is a scholar working on Biomaterials, Molecular Biology and Surgery. According to data from OpenAlex, David C. Gillis has authored 23 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomaterials, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in David C. Gillis's work include Pharmacogenetics and Drug Metabolism (3 papers), Microscopic Colitis (3 papers) and Supramolecular Self-Assembly in Materials (3 papers). David C. Gillis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Microscopic Colitis (3 papers) and Supramolecular Self-Assembly in Materials (3 papers). David C. Gillis collaborates with scholars based in United States, Australia and Denmark. David C. Gillis's co-authors include Ross A. James, Melina R. Kibbe, Nick D. Tsihlis, Artem S. Rogovskyy, Samuel I. Stupp, Mark R. Karver, Janet K. Coller, Fiona M. Thompson, Emma Southcott and Ross N. Butler and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

David C. Gillis

22 papers receiving 329 citations

Peers

David C. Gillis
Jim Blanchard United States
Marika Arthur United States
Linda E. Rosenthal United States
Jim Blanchard United States
David C. Gillis
Citations per year, relative to David C. Gillis David C. Gillis (= 1×) peers Jim Blanchard

Countries citing papers authored by David C. Gillis

Since Specialization
Citations

This map shows the geographic impact of David C. Gillis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Gillis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Gillis more than expected).

Fields of papers citing papers by David C. Gillis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Gillis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Gillis. The network helps show where David C. Gillis may publish in the future.

Co-authorship network of co-authors of David C. Gillis

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Gillis. A scholar is included among the top collaborators of David C. Gillis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Gillis. David C. Gillis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siletzky, Robin, et al.. (2025). Apolipoprotein E Deficiency Produces an Inflammatory Abdominal Aortic Aneurysm in a Rat Calcium Chloride-Induced Model. Journal of Surgical Research. 312. 83–93.
2.
Gillis, David C., et al.. (2023). Systemic peptide amphiphile nanofiber delivery following subcutaneous injection. Biomaterials. 303. 122401–122401. 5 indexed citations
3.
Akerman, Adam W., David C. Gillis, Smaranda Willcox, et al.. (2022). Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms. ACS Nano. 16(5). 7309–7322. 14 indexed citations
4.
Gillis, David C., Nick D. Tsihlis, Mark R. Karver, et al.. (2021). Intravenous Delivery of Lung‐Targeted Nanofibers for Pulmonary Hypertension in Mice. Advanced Healthcare Materials. 10(13). e2100302–e2100302. 16 indexed citations
5.
Gillis, David C., Tristan D. Clemons, Smaranda Willcox, et al.. (2021). Development of novel nanofibers targeted to smoke-injured lungs. Biomaterials. 274. 120862–120862. 8 indexed citations
6.
Yu, Lu, David C. Gillis, Brian C. Cooley, et al.. (2021). Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia. Biomaterials Science. 9(15). 5160–5174. 11 indexed citations
7.
Gillis, David C., et al.. (2020). Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury. Nanomaterials. 10(3). 420–420. 8 indexed citations
8.
Gillis, David C., et al.. (2020). A comparative study of a preclinical survival model of smoke inhalation injury in mice and rats. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(3). L471–L480. 6 indexed citations
9.
Gillis, David C., Jeong Ho Jeon, Jung Hun Lee, et al.. (2019). The Occurrence and Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolated from Clinical Diagnostic Specimens of Equine Origin. Animals. 10(1). 28–28. 7 indexed citations
10.
Rogovskyy, Artem S., et al.. (2018). Phenotypic and genotypic characteristics of Trueperella pyogenes isolated from ruminants. Journal of Veterinary Diagnostic Investigation. 30(3). 348–353. 22 indexed citations
11.
Rogovskyy, Artem S., et al.. (2017). Diversity of Borrelia spirochetes and other zoonotic agents in ticks from Kyiv, Ukraine. Ticks and Tick-borne Diseases. 9(2). 404–409. 25 indexed citations
12.
Rogovskyy, Artem S., David C. Gillis, Yurij Ionov, Ekaterina S. Gerasimov, & Alex Zelikovsky. (2016). Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion. Infection and Immunity. 85(1). 12 indexed citations
13.
Gillis, David C., et al.. (2013). Nebulin binding impedes mutant desmin filament assembly. Molecular Biology of the Cell. 24(12). 1918–1932. 11 indexed citations
14.
Coller, Janet K., Christel Joergensen, David Foster, et al.. (2007). Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone. International Journal of Clinical Pharmacology and Therapeutics. 45(7). 410–417. 24 indexed citations
15.
Coller, Janet K., et al.. (2004). A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis. International Journal of Clinical Pharmacology and Therapeutics. 42(12). 719–723. 18 indexed citations
16.
Davies, Benjamin J., Janet K. Coller, David C. Gillis, et al.. (2004). Clinical inhibition of CYP2D6‐catalysed metabolism by the antianginal agent perhexiline. British Journal of Clinical Pharmacology. 57(4). 456–463. 6 indexed citations
17.
Gillis, David C., et al.. (2002). An autopsy approach to bee sting-related deaths. Pathology. 34(3). 257–262. 42 indexed citations
18.
Cummins, Adrian G., et al.. (2001). Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clinical Science. 100(4). 379–379. 31 indexed citations
19.
Cummins, Adrian G., et al.. (2001). Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clinical Science. 100(4). 379–386. 17 indexed citations
20.
Devine, Peter L., Geoffrey W. Birrell, Michael N. Marsh, et al.. (1994). Screening and Monitoring Coeliac Disease: Multicentre Trial of a New Serum Antibody Test Kit. Disease Markers. 12(1). 71–80. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026